Medication info

Samsung Linagliptin Duo Tablet 2.5/500 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Linagliptin›2.5mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Samsung Pharmaceutical Co., Ltd.
Appearance
Bright yellow oval film-coated tablet
Packaging
60 tablets/PTP[(10 tablets/PTP×6)]
Approval status
Expired

MFDS item code 201907497 · Approved 2019.10.28

This product's status changed to Expired on 2024.10.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this drug should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of each component: linagliptin 2.5 mg and metformin 1000 mg twice daily. This drug is administered twice daily with meals. Dose increases should be gradual to reduce gastrointestinal adverse reactions associated with metformin use. 1. Patients not currently receiving metformin: For patients with no previous experience of antidiabetic drug treatment who cannot achieve adequate glycemic control with monotherapy, the initial dose is 1 tablet of this drug 2.5/500 mg twice daily; the dose may be increased to 1 tablet of this drug 2.5/1000 mg twice daily. 2. Patients switching from combination therapy with linagliptin and metformin: Patients switching from combination therapy with linagliptin and metformin to this drug should start at the same doses of linagliptin and metformin they were previously taking. 3. Patients unable to achieve adequate glycemic control with combination therapy of insulin and metformin: The initial dose of this drug should be considered as linagliptin 2.5 mg twice daily (total daily dose 5 mg) and a dose similar to the patient's current metformin dose. When this drug is administered with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia (see Precautions for Use, 2. Use with caution in the following patients). Patients with renal impairment This drug may be used, with the following dose adjustment, in patients with moderate renal impairment stage 3a (creatinine clearance [CrCl] 45≤~<60 ml/min or estimated glomerular filtration rate (eGFR) 45≤~<60 mL/min/1.73 m2) who do not have other conditions that may increase the risk of lactic acidosis. Because the starting dose of metformin is 500mg or 850mg once daily, treatment should not be initiated with this drug. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this drug should be discontinued immediately.

Ingredients

Manufacturer
Samsung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Difficulty in blood sugar control in adults with type 2 diabetes
View approved original text

This medication helps adults with type 2 diabetes to manage blood sugar levels more effectively while following dietary and exercise recommendations. It is particularly used for patients who have not previously received diabetes medication or where blood sugar control is difficult with monotherapy. It can also be used in conjunction with insulin when blood sugar control is insufficient with insulin and metformin combination therapy. In cases where blood sugar control is difficult even with the maximum doses of metformin and empagliflozin, it is used in combination with empagliflozin. This medication is effective in improving blood sugar control in various situations.

How to take

Adult dose

The dose of this drug should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of each component: linagliptin 2.5 mg and metformin 1000 mg twice daily. This drug is administered twice daily with meals. Dose increases should be gradual to reduce gastrointestinal adverse reactions associated with metformin use. 1. Patients not currently receiving metformin: For patients with no previous experience of antidiabetic drug treatment who cannot achieve adequate glycemic control with monotherapy, the initial dose is 1 tablet of this drug 2.5/500 mg twice daily; the dose may be increased to 1 tablet of this drug 2.5/1000 mg twice daily. 2. Patients switching from combination therapy with linagliptin and metformin: Patients switching from combination therapy with linagliptin and metformin to this drug should start at the same doses of linagliptin and metformin they were previously taking. 3. Patients unable to achieve adequate glycemic control with combination therapy of insulin and metformin: The initial dose of this drug should be considered as linagliptin 2.5 mg twice daily (total daily dose 5 mg) and a dose similar to the patient's current metformin dose. When this drug is administered with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia (see Precautions for Use, 2. Use with caution in the following patients). Patients with renal impairment This drug may be used, with the following dose adjustment, in patients with moderate renal impairment stage 3a (creatinine clearance [CrCl] 45≤~<60 ml/min or estimated glomerular filtration rate (eGFR) 45≤~<60 mL/min/1.73 m2) who do not have other conditions that may increase the risk of lactic acidosis. Because the starting dose of metformin is 500mg or 850mg once daily, treatment should not be initiated with this drug. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this drug should be discontinued immediately.

Precautions

This medication is composed of two components, metformin and linagliptin, and is primarily used for the treatment of type 2 diabetes. This medication can cause a very rare but serious side effect known as lactic acidosis, and should not be administered to patients with severely impaired kidney function, liver dysfunction, or acute heart failure. Additionally, it should not be used in patients who are allergic to the components of this medication, those with type 1 diabetes, women who are pregnant or breastfeeding, or individuals with acute alcohol intoxication. During the course of taking this medication, symptoms of hypoglycemia may occur, and blood sugar should be monitored regularly, especially when taken with insulin or sulfonylurea medications, and patients should consult a doctor immediately if symptoms arise. In patients with impaired kidney function or conditions that may affect kidney function, such as acute infections, dehydration, or severe trauma, the use of this medication should be temporarily suspended, and it can be resumed once kidney function stabilizes. Caution is also required in patients with liver dysfunction, and adjustments may need to be made in cases of severe gastrointestinal disorders. If conditions such as acute pancreatitis or bullous pemphigoid are suspected, the medication should be discontinued immediately and a healthcare professional should be consulted. This medication may reduce vitamin B12 levels, so if taken over a long period, regular assessment of vitamin B12 levels is recommended. Caution is advised when taken in combination with other medications due to potential interactions, especially with drugs that may affect kidney function, and management should be carried out according to a doctor’s instructions. Women who are pregnant or planning to become pregnant are advised not to take this medication, and breastfeeding women should also avoid it. It is advisable not to use this medication in children under 10 years of age as safety and efficacy have not been established. In elderly patients, since impaired kidney function is common, it is recommended to administer the minimum dose while regularly monitoring kidney function and to avoid maximum dosing. In cases of overdose, serious side effects such as lactic acidosis may occur; therefore, it is important to seek immediate medical attention for appropriate treatment. This medication should be stored in a tightly sealed container, away from moisture and direct sunlight, and should not be transferred to other containers.

Side effects

  • Lactic acidosis
  • nasopharyngitis
  • hypersensitivity
  • angioedema
  • urticaria
  • decrease and deficiency of vitamin B12
  • hypoglycemia
  • taste disorders
  • cough
  • decreased appetite
Show 158 more
  • diarrhea
  • constipation
  • nausea
  • pancreatitis
  • vomiting
  • abdominal pain
  • oral ulcer formation
  • liver function test abnormalities
  • hepatitis
  • pruritus
  • erythema
  • rash
  • vesicular pemphigoid
  • severe and debilitating arthralgia
  • rhabdomyolysis
  • increased lipase
  • increased amylase
  • gastroenteritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • septicemia
  • pneumonia
  • constipation
  • upper abdominal pain
  • enterocolitis
  • intestinal obstruction
  • gastroenteritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • septicemia
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disorders
  • Alzheimer's dementia
  • chest pain
  • fever
  • facial swelling
  • fatigue
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • gastric cancer
  • colorectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • pneumonia
  • hypertension
  • anxiety
  • insomnia
  • depression
  • contusion
  • bone contusion
  • concussion
  • bone fracture
  • hand fracture
  • laceration
  • palpitations
  • dry eye
  • cataract
  • ocular discomfort
  • allergic conjunctivitis
  • polyuria
  • hypotension
  • flushing
  • hepatic steatosis
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • cholelithiasis
  • hearing loss
  • erectile dysfunction
  • goiter
  • anemia
  • dizziness
  • itching
  • delirium
  • nocturia
  • dermatitis
  • hypertension
  • angina
  • acute myocardial infarction
  • unstable angina
  • diarrhea
  • stomatitis
  • stomatitis
  • mediastinitis
  • pneumonia
  • rhinitis
  • fever
  • ligament sprain
  • flank pain
  • myelodysplastic syndrome
  • vocal cord polyp
  • dyspepsia
  • upper abdominal pain
  • rectal bleeding
  • cheilitis
  • dental caries
  • enteritis
  • gastritis
  • stomatitis
  • dizziness
  • diabetic neuropathy
  • headache
  • subdural effusion
  • angina
  • acute myocardial infarction
  • unstable angina
  • corneal abrasion
  • falls
  • ligament sprain
  • upper extremity fracture
  • voice disorder
  • dyspnea
  • epistaxis
  • dizziness
  • dyslipidemia
  • hypercholesterolemia
  • osteoarthritis
  • limb pain
  • rotator cuff syndrome
  • androgenetic alopecia
  • hyperhidrosis
  • hair loss
  • dermatitis
  • anxiety
  • depression
  • insomnia
  • hypertension
  • benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. It is best stored at room temperature between 1 and 30 degrees Celsius. This helps to maintain the effectiveness of the medication over time.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablet

Package unit

60 tablets/PTP[(10 tablets/PTP×6)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.